Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells

Leukemia

Volumn 13, Issue 6, 1999, Pages 910-917

  Fryxell, K B ^a   McGee, S B ^a   Simoneaux, D K ^a   Willman, C L ^b   Cornwell, M M ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Acute myeloid leukemia; Bisulphite sequencing; CpG island; MDR1; Methylation; Multidrug resistance

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; CPG ISLAND; EXON; GENE EXPRESSION REGULATION; GENE LOCUS; GENE OVEREXPRESSION; GENE SEQUENCE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INTRON; MEMBRANE TRANSPORT; METHYLATION; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE SUBPOPULATION; TREATMENT FAILURE;

EID: 0032969236     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401424     Document Type: Article

References (51)

1. Hayes JD, Wolf CR. Molecular mechanisms of drug resistance. Biochem J 1990; 272: 281-295.
2. Kane SE. Multidrug resistance of cancer cells. Adv Drug Res 1996; 28: 181-252.
3. Cornwell MM. Regulation of MDR genes. In: Gupta S, Tsuruo T (eds). Multidrug Resistance in Cancer Cells. John Wiley & Sons: New York, 1996, pp 39-48.
4. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM, Head DR, Appelbaum FR, Willman CL. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323-3329.
5. Willman CL. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program. Semin Hematol 1997; 34: 25-33.
6. McCoy C, Smith DE, Cornwell MM. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol Cell Biol 1995; 15: 6100-6108.
7. Cornwell MM, Smith DE. SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J Biol Chem 1993; 268: 19505-19511.
8. Cornwell MM, Smith DE. A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase. J Biol Chem 1993; 268: 15347-15350.
9. Cornwell MM. The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription. Cell Growth Differ 1990; 1: 607-615.
10. Fedor MJ. Chromatin structure and gene expression. Curr Opin Cell Biol 1992; 4: 436-443.
11. Felsenfeld G. Chromatin as an essential part of the transcriptional mechanism. Nature 1992; 355: 219-224.
12. Wolffe AP. The transcription of chromatin templates. Curr Opin Genet Dev 1994; 4: 245-254.
13. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209-213.
14. Antequera F, Boyes J, Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990; 62: 503-514.
15. Tazi J, Bird A. Alternative chromatin structure at CpG islands. Cell 1990; 60: 909-920.
16. Cross SH, Bird AP. CpG islands and genes (review). Curr Opin Genet Dev 1995; 5: 309-314.
17. Bird AP. The relationship of DNA methylation to cancer (review). Cancer Surv 1996; 28: 87-101.
18. Jones PA. DNA methylation errors and cancer. Cancer Res 1996; 56: 2463-2467.
19. Stoger R, Kajimura TM, Brown WT, Laird CD. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet 1997; 6: 1791-1801.
20. Kawai J, Hirotsune S, Hirose K, Fushiki S, Watanabe S, Hayashizaki Y. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucleic Acids Res 1993; 21: 5604-5608.
21. Wolf SF, Jolly DJ, Lunnen KD, Friedmann T, Migeon BR. Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc Natl Acad Sci USA 1984; 81: 2806-2810.
22. Wada F, Kusaba H, Nakayama M, Harada T, Torigoe K, Kohno K, Sugio K, Kozuru M, Kuwano M. 5′ CpG island demethylation is associated with transcriptional activation of the human multidrug-resistance 1 (MDR1) gene in human tumors. AACR 1997; 38: 480 (Abstr.).
23. Efferth T, Fabry U, Osieka R. Modulation of MDR1 gene expression and function in human K562 leukemic cells by 5-azacytidine. AACR 1997; 38: 480.
24. Mirrione A, Seree E, Rimet O, Barra Y. Hypomethylation and hypoexpression of the human MDR1 gene. AACR 1996; 37: 538.
25. Futscher BW, Dalton WS. Activation of MDR1 gene expression is associated with cytosine methylation of its CpG island. AACR 1996; 37: 315.
26. Kantharidis P, El-Osta A, deSilva M, Wall DMP, Hu XF, Slater A, Nadalin G, Parkin JD, Zalcberg JR. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. Clin Cancer Res 1997; 3: 2025-2032.
27. Kusaba H, Nakayama M, Harada T, Torigoe K, Green ED, Scherer SW, Kohno K, Kuwano M, Wada M. Maintenance of hypomethylation status and preferential expression of exogenous human MDR1/PGY1 gene in mouse L cells by YAC mediated transfer. Somat Cell Mol Genet 1997; 23: 259-274.
28. Desiderato L, Davey MW, Piper AA. Demethylation of the human MDR1 5′ region accompanies activation of P-glycoprotein expression in a HL60 multidrug resistant subline. Somat Cell Mol Genet 1997; 23: 391-400.
29. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990-2997.
30. Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 1993; 85: 632-639.
31. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 1992; 80: 2729-2734.
32. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HS, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 1996; 56: 3010-3020.
33. Dalton WS, Grogan TM, Rybski JA, Scheper RJ, Richter L, Kailey J, Broxterman HJ, Pinedo HM, Salmon SE. Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation. Blood 1989; 73: 747-752.
34. Su GM, Davey MW, Davey RA, Kidman AD. Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells. Br J Haematol 1994; 88: 566-574.
35. Chaudhary PM, Roninson IB. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol Res 1992; 4: 281-290.
36. Leith CP, Chen IM, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux-cases. Blood 1995; 86: 2329-2342.
37. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 7160-7164.
38. Riddell SR, Greenberg PD. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Meth 1990; 128: 189-201.
39. Ueda K, Pastan I, Gottesman MM. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J Biol Chem 1987; 262: 17432-17436.
40. Kohno K, Sato S, Uchiumi T, Takano H, Kato S, Kuwano M. Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene. J Biol Chem 1990; 265: 19690-19696.
41. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196: 261-282.
42. Song JJ, Walker S, Chen E, Johnson EE, Spychala J, Gribbin T, Mitchell BS. Genomic structure and chromosomal localization of the human deoxycytidine kinase gene. Proc Natl Acad Sci USA 1993; 90: 431-434.
43. Dodge JE, List AF, Futscher BW. Selective variegated methylation of the p15 CpG island in acute myeloid leukemia. Int J Cancer 1998; 78: 561-567.
44. Klimecki T, Futscher BW, Grogan TM, Dalton WS. P-Glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 1994; 83: 1-8.
45. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995; 55: 4531-4535.
46. Mickley LA, Spengler BA, Knutsen TA, Biedler JL, Fojo T. Gene rearrangement: a novel mechanism for MDR-1 gene activation. J Clin Invest 1997; 99: 1947-1957.
47. Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W, Bates SE, Fojo T. Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood 1998; 91: 1749-1756.
48. Hellmann-Blumberg U, Hintz MF, Gatewood JM, Schmid CW. Developmental differences in methylation of human Alu repeats. Mol Cell Biol 1993; 13: 4523-4530.
49. Schmid CW. Human Alu subfamilies and their methylation revealed by blot hybridization. Nucleic Acids Res 1991; 19: 5613-5617.
50. Kochanek S, Renz D, Doerfler W. DNA methylation in the Alu sequences of diploid and haploid primary human cells. EMBO J 1993; 12: 1141-1151.
51. Rubin CM, Vande Voort CA, Teplitz RL, Schmid CW. Alu repeated DNAs are differentially methylated in primate germ cells. Nucleic Acids Res 1994; 22: 5121-5127.